Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1340 NDI-101150 is a potent and highly selective hematopoietic progenitor kinase 1 (HPK1) inhibitor that promotes a robust and broad anti-tumor immune response
Compose a Response to This Article
Other responses
No responses have been published for this article.
